AstraZeneca Pledges $15B in China as UK Strengthens Science Ties
AstraZeneca announces $15 billion investment in China through 2030, bolstering UK-China science ties amid Prime Minister Starmer’s diplomatic engagement.
AstraZeneca
Read More
AstraZeneca Commits $15B to China Amid Healthcare Expansion
AstraZeneca announces $15B China investment during UK PM Starmer’s visit, signaling confidence in the country’s healthcare reforms and innovation ecosystem.
AstraZeneca to Launch 100 New Medicines in China, Boosting Shanghai R&D Collaboration
AstraZeneca plans to launch over 100 new medicines in China within five years, strengthening collaboration through its Shanghai R&D center, according to EVP Sharon Barr.
AstraZeneca: “China Is the Best Location for Innovation” with $700 Million Investment
AstraZeneca invested $700 million in an inhaled medicines manufacturing site in Qingdao City, Shandong Province. EVP Leon Wang declared “China is the best location for innovation.”
AstraZeneca CEO Praises China’s Growth and Supply Chain Efficiency
AstraZeneca CEO Pascal Soriot expresses strong confidence in China’s economic growth and supply chain efficiency, highlighting its strategic importance to the company’s global operations.
China set to lead next wave of biopharmaceutical innovation, says AstraZeneca CEO
Pascal Soriot, CEO of AstraZeneca, highlights China’s pivotal role in driving innovation in biopharmaceuticals at the Boao Forum 2024, noting the creation of well-paid jobs and a focus on quality productive forces.
AstraZeneca Deepens Roots in China’s Pharmaceutical Landscape
AstraZeneca amplifies its presence in China with significant investments in Wuxi and Qingdao, focusing on innovation and R&D to advance global health and economic growth.
South Africa Begins COVID-19 Vaccinations with Johnson & Johnson Vaccine
South Africa starts COVID-19 vaccinations with Johnson & Johnson after pausing AstraZeneca due to variant efficacy concerns.